Jane Street’s Oramed Pharmaceuticals ORMP Stock Holding History

Jane Street’s Portfolio ORMP Stock Details ORMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-78,100	Closed	-$506K	–	9849
2022 Q3	$506K	Buy	78,100 +65,400	+515%	+$529K	﹤0.01%	6675
2022 Q2	$58K	Sell	12,700 -28,800	-69%	-$154K	﹤0.01%	8880
2022 Q1	$359K	Sell	41,500 -52,800	-56%	-$541K	﹤0.01%	8084
2021 Q4	$1.35M	Sell	94,300 -18,000	-16%	-$376K	﹤0.01%	5306
2021 Q3	$2.47M	Buy	+112,300	New	+$1.91M	﹤0.01%	4042

Other funds holding ORMP

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street's ORMP Position: Q1 2026 in Review

Jane Street reduced its Oramed Pharmaceuticals (ORMP) stake by 33% in Q1 2026, selling an estimated $87.3K and leaving 52,540 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #10256.

Jane Street first reported a position in ORMP in Q1 2014 and has held it in 27 quarters since. The position peaked at $1.6M in Q4 2022. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

Jane Street held 52,540 shares of Oramed Pharmaceuticals worth $179K as of Q1 2026.
Jane Street sold 25,719 Oramed Pharmaceuticals shares in Q1 2026, an estimated $87.3K.
Oramed Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10256 holding.
Jane Street first reported a position in Oramed Pharmaceuticals in Q1 2014 and has held it in 27 quarters since.
Jane Street's Oramed Pharmaceuticals position peaked at $1.6M in Q4 2022.
64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.